IDT Australia Ltd
IDT
Company Profile
Business description
IDT Australia Ltd engages in the supply of products and provision of research and development and other technical services within the pharmaceutical and allied industries. It derives revenue from development and manufacturing of Active Pharmaceutical Ingredients (API), formulation and manufacture of Speciality Orals (medicinal cannabis) and Advanced Therapies, in Finished Dose Forms (FDF) as well as provision of Research & Development services. The company operates in a single segment of the development and manufacture of active pharmaceutical ingredients (API) and finished dose forms (FDF).
Contact
45 Wadhurst Drive
Boronia
MelbourneVIC3155
AUST: +61 398018888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
156
Stocks News & Analysis
stocks
ASX rare earths play looks to expand production
The largest rare-earth producer outside of China acquires competitor to increase production.
stocks
Anthropic’s leaked financials reflect fast growth, but not a $2 trillion valuation
Draft IPO filing shows a company growing faster than its annual results can capture.
stocks
The 10 best US companies to invest in now
The stocks of these high-quality companies look cheap today.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,919.70 | 60.50 | 0.68% |
| CAC 40 | 7,834.10 | 63.09 | -0.80% |
| DAX 40 | 25,254.21 | 23.01 | 0.09% |
| Dow JONES (US) | 51,267.90 | 90.94 | 0.18% |
| FTSE 100 | 10,497.94 | 35.99 | 0.34% |
| HKSE | 24,222.72 | 182.38 | 0.76% |
| NASDAQ | 27,477.31 | 286.45 | 1.05% |
| Nikkei 225 | 70,081.53 | 134.67 | 0.19% |
| NZX 50 Index | 13,705.69 | 6.67 | 0.05% |
| S&P 500 | 7,773.95 | 51.23 | 0.66% |
| S&P/ASX 200 | 8,752.80 | 66.40 | 0.76% |
| SSE Composite Index | 3,842.19 | 11.74 | 0.31% |